TY Howton
Chief Operating Officer presso SOLID BIOSCIENCES INC.
Patrimonio netto: 102 351 $ in data 31/03/2024
Profilo
David Tyronne Howton is currently the Chief Operating Officer at Solid Biosciences, Inc. He previously held positions as Director at Make-A-Wish Foundation of Massachusetts, Chief Healthcare Compliance Officer at Genentech, Inc., Secretary, Chief Legal Officer & Senior VP at Vertex Pharmaceuticals, Inc., Secretary, Senior Vice President & General Counsel at Sarepta Therapeutics, Inc., and Chief Operating Officer & General Counsel at Aavantibio, Inc. He obtained his undergraduate degree from Yale University and his graduate degree from Northwestern University School of Law.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
SOLID BIOSCIENCES INC.
0.02% | 13/02/2024 | 7 684 ( 0.02% ) | 102 351 $ | 31/03/2024 |
Posizioni attive di TY Howton
| Società | Posizione | Inizio |
|---|---|---|
| SOLID BIOSCIENCES INC. | Chief Operating Officer | 01/09/2023 |
Precedenti posizioni note di TY Howton
| Società | Posizione | Fine |
|---|---|---|
Aavantibio, Inc.
 Aavantibio, Inc. BiotechnologyHealth Technology Aavantibio, Inc. engages in developing gene therapies. The company was founded by Barry Byrne and Manuela Corti and is headquartered in Gainesville, FL. | Chief Operating Officer | 01/12/2022 |
| SAREPTA THERAPEUTICS, INC. | General Counsel | - |
| VERTEX PHARMACEUTICALS INCORPORATED | General Counsel | 12/06/2012 |
| Make-A-Wish Foundation of Massachusetts | Director/Board Member | - |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
Formazione di TY Howton
| Yale University | Undergraduate Degree |
| Northwestern University School of Law | Graduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| SAREPTA THERAPEUTICS, INC. | Health Technology |
| SOLID BIOSCIENCES INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
| Make-A-Wish Foundation of Massachusetts | |
Aavantibio, Inc.
Aavantibio, Inc. BiotechnologyHealth Technology Aavantibio, Inc. engages in developing gene therapies. The company was founded by Barry Byrne and Manuela Corti and is headquartered in Gainesville, FL. | Health Technology |
- Borsa valori
- Insiders
- TY Howton
